Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Migoprotafib |
| Trade Name | |
| Synonyms | RLY1971|RLY 1971|RG-6433|RG6433|RLY-1971|GDC 1971|GDC-1971|GDC1971 |
| Drug Descriptions |
Migoprotafib is a selective SHP2 inhibitor, which potentially decreases tumor growth (PMID: 37774359, PMID: 39632729). |
| DrugClasses | SHP2 Inhibitor 20 |
| CAS Registry Number | 2377352-49-1 |
| NCIT ID | C172988 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + Migoprotafib | Atezolizumab Migoprotafib | 0 | 1 |
| Atezolizumab + Migoprotafib + Omeprazole | Atezolizumab Migoprotafib Omeprazole | 0 | 1 |
| Cetuximab + Migoprotafib | Cetuximab Migoprotafib | 0 | 1 |
| Divarasib + Migoprotafib | Divarasib Migoprotafib | 0 | 0 |
| Migoprotafib | Migoprotafib | 0 | 1 |
| Migoprotafib + Osimertinib | Migoprotafib Osimertinib | 0 | 1 |